SteraMist iHP GLP Study
This paper addresses the issues of getting a hospital disinfectant approved by the EPA, some of the challenges encountered and results achieved for a number of hospital related pathogens including MRSA, Pseudomonas sp., H1N1, etc. using a novel approach. The paper also addresses the differences between hands-free and wipes technologies, sprays, and their approval pathways.
The paper presents the results from Good Laboratory Practice Studies (GLP) submitted to EPA for a novel technology using The SteraMist Surface and Environmental systems. SteraMist Binary Ionization Technology (BIT) converts a 7.8% hydrogen peroxide solution into a Hydroxyl Radical mist. This EPA-registered solution is passed through an atmospheric cold plasma arc where activation occurs.
Complete the form below to download the white paper.
The Invisible War
Protecting Your Space from Flu subclade K and Emerging PathogensWhen one reads the word “War,” one first thinks of armies, explosions, crippling power grids, disruption of information systems, broken financial systems, and government networks. Rarely do you hear about “The Invisible War”…
Fighting Christmas Tree Contagions
What’s prickly, green, and can sneakily steal away the holiday season? If you answered “The Grinch”, you’d be off the mark. With the holidays approaching quickly, major health concerns can threaten the festive spirit: The relentless winter flu and norovirus season and an additional…
The Risks of Residues
Why What’s Left Behind Matters“Clean” often implies “safe.” But what if the very products designed to make spaces safe are leaving behind hidden dangers? Disinfection residues, often invisible to the naked eye, can have significant implications for health, material integrity, and even the effectiveness…